Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.
Targeting insulin resistance may result in a list of benefits for women with PCOS, including hormonal, metabolic and ovulatory (and fertility) improvements. The therapeutic strategy to treat PCOS should however depend on the clinical situation, the phenotype, the degree of androgen excess, age, the presence of infertility and the woman's desire to conceive, the presence of obesity and, finally, the spectrum of metabolic abnormalities and the need to treat or prevent long-term associated comorbidities. According to the needs, therapeutic options include, alone or in combination, lifestyle management, particularly in the presence of obesity, the use of insulin sensitizers, metformin and thiazolidinediones, antiandrogens or estro-progestins.
Pasquali
Renato
R
University Alma Mater Studiorum, S. Orsola-Malpighi Hospital, Division of Endocrinology, Department of Clinical Medicine, Bologna, Italy. renato.pasquali@unibo.it
Gambineri
Alessandra
A
D005260:Female; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance / Q000502:physiology*; D009765:Obesity; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy* / Q000378:metabolism
D007004:Hypoglycemic Agents; D005947:Glucose